• An antiplatelet drug (antiaggregant), also known as a platelet agglutination inhibitor or platelet aggregation inhibitor, is a member of a class of pharmaceuticals...
    18 KB (1,752 words) - 10:58, 11 August 2024
  • Thumbnail for Anticoagulant
    related to antiplatelet drugs and thrombolytic drugs by manipulating the various pathways of blood coagulation. Specifically, antiplatelet drugs inhibit...
    78 KB (8,755 words) - 07:51, 27 October 2024
  • Thumbnail for Dipyridamole
    Dipyridamole (category Antiplatelet drugs)
    Dipyridamole (trademarked as Persantine and others) is an antiplatelet drug of the nucleoside transport inhibitor and PDE3 inhibitor class that inhibits...
    11 KB (891 words) - 17:40, 20 November 2024
  • Thumbnail for Clopidogrel
    Clopidogrel (category Multiple chemicals in Infobox drug)
    Clopidogrel, sold under the brand name Plavix among others, is an antiplatelet medication used to reduce the risk of heart disease and stroke in those...
    44 KB (3,710 words) - 04:08, 21 November 2024
  • The following are medications commonly prescribed cardiac pharmaceutical agents. The specificity of the following medications is highly variable, and often...
    5 KB (345 words) - 07:24, 2 July 2024
  • Thumbnail for Cannabis (drug)
    (2020). "A review of cannabis and interactions with anticoagulant and antiplatelet agents". The Journal of Clinical Pharmacology. 60 (4): 432–38. doi:10...
    165 KB (17,231 words) - 03:53, 17 November 2024
  • Thumbnail for Ticlopidine
    Ticlopidine (category Multiple chemicals in Infobox drug)
    medication used to reduce the risk of thrombotic strokes. It is an antiplatelet drug in the thienopyridine family which is an adenosine diphosphate (ADP)...
    18 KB (1,724 words) - 08:54, 9 September 2024
  • Thumbnail for Cangrelor
    Cangrelor (category Multiple chemicals in Infobox drug)
    among others, is a P2Y12 inhibitor FDA approved as of June 2015 as an antiplatelet drug for intravenous application. Some P2Y12 inhibitors are used clinically...
    15 KB (1,150 words) - 05:23, 3 March 2024
  • Thumbnail for Aspirin
    Aspirin (redirect from Treo (drug))
    Khan MZ, et al. (October 2020). "Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and...
    155 KB (16,756 words) - 20:21, 11 November 2024
  • Thumbnail for Medication
    Medication (redirect from Blockbuster drug)
    Coagulation: anticoagulants, heparin, antiplatelet drugs, fibrinolytics, anti-hemophilic factors, haemostatic drugs. General: β-receptor blockers ("beta...
    69 KB (7,416 words) - 16:21, 10 November 2024
  • Thumbnail for Cilostazol
    Cilostazol (category Antiplatelet drugs)
    Hori S, Sawada Y (October 2007). "Possible case of potentiation of the antiplatelet effect of cilostazol by grapefruit juice". Journal of Clinical Pharmacy...
    9 KB (689 words) - 06:23, 24 January 2023
  • Thumbnail for Gangrene
    circulatory system management is important. These medications can include antiplatelet drug, anticoagulant, and fibrinolytics. As infection is often associated...
    27 KB (2,796 words) - 14:47, 17 October 2024
  • Cardiovascular agents (category Drugs acting on the cardiovascular system)
    PMID 36906198. Drug Office (September 2014). "Oral Anticoagulants and Antiplatelet Drugs". Born, Gustav; Patrono, Carlo (2006). "Antiplatelet drugs". British...
    46 KB (5,036 words) - 18:54, 5 November 2024
  • Thumbnail for Management of acute coronary syndrome
    anti-inflammatory drugs are contraindicated for both categories of patients. All patients with acute coronary syndrome must immediately receive antiplatelet therapy...
    54 KB (5,225 words) - 10:48, 21 July 2024
  • Thumbnail for Vertebral artery dissection
    disorder affecting the blood vessels. Treatment is usually with either antiplatelet drugs such as aspirin or with anticoagulants such as heparin or warfarin...
    37 KB (4,360 words) - 17:27, 18 October 2024
  • Adenosine diphosphate (ADP) receptor inhibitors are a drug class of antiplatelet agents, used in the treatment of acute coronary syndrome (ACS) or in preventive...
    46 KB (5,282 words) - 08:16, 30 March 2024
  • Thumbnail for Drug interaction
    In pharmaceutical sciences, drug interactions occur when a drug's mechanism of action is affected by the concomitant administration of substances such...
    29 KB (2,971 words) - 18:21, 3 September 2024
  • Thumbnail for Eptifibatide
    Eptifibatide (category Drug has EMA link)
    Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic...
    11 KB (947 words) - 16:29, 11 May 2024
  • Thumbnail for Myocardial infarction
    outcomes, and there is some evidence of potential harm. Aspirin, an antiplatelet drug, is given as a loading dose to reduce the clot size and reduce further...
    129 KB (13,821 words) - 06:58, 18 November 2024
  • Thumbnail for Thrombosis prevention
    Thrombosis prevention (category Antiplatelet drugs)
    clotting cascade and changing the proteins that are needed for clotting. Antiplatelet drugs also have an effect in preventing the formation of clots.[citation...
    54 KB (3,704 words) - 19:53, 21 October 2024
  • Thumbnail for Natural product
    saw-scaled viper Echis carinatus was a lead in the development of the antiplatelet drug tirofiban. In addition to the terrestrial animals and amphibians described...
    117 KB (12,419 words) - 18:47, 17 November 2024
  • Thumbnail for Tirofiban
    Tirofiban (category Drugs with non-standard legal status)
    sold under the brand name Aggrastat, is an antiplatelet medication. It belongs to a class of antiplatelets named glycoprotein IIb/IIIa inhibitors. Tirofiban...
    11 KB (1,002 words) - 23:55, 14 March 2024
  • Thumbnail for Fenugreek
    may interfere with the activity and dosing of anticoagulants and antiplatelet drugs. Fenugreek sprouts, cultivated from a single specific batch of seeds...
    20 KB (2,198 words) - 09:50, 16 November 2024
  • Thumbnail for Reye syndrome
    Syndrome | NYP". NewYork-Presbyterian. Retrieved May 26, 2024. "2.9 Antiplatelet drugs". British National Formulary for Children. British Medical Association...
    23 KB (2,382 words) - 11:39, 13 October 2024
  • Thumbnail for Vorapaxar
    Vorapaxar (category Chemical pages without DrugBank identifier)
    vorapaxar is not recommended due to the risk of bleeding. Vorapaxar is an antiplatelet drug of the PAR-1 antagonist family. It functions by inhibiting thrombin-related...
    12 KB (995 words) - 09:08, 5 September 2024
  • Thumbnail for Thrombosis
    thrombosis is platelet-rich, and inhibition of platelet aggregation with antiplatelet drugs such as aspirin may reduce the risk of recurrence or progression....
    47 KB (4,766 words) - 01:48, 19 October 2024
  • people. Glenn King discusses the current state of venom-derived drugs, with six drugs derived from venom being FDA-approved and ten more currently being...
    33 KB (3,653 words) - 21:13, 30 September 2024
  • at the same time as other blood thinning drugs such as nonsteroidal anti-inflammatory drugs, antiplatelet drugs and heparin. The blood thinning effects...
    16 KB (1,525 words) - 03:57, 3 February 2024
  • Antithrombotic (category Blood and blood forming organ drug stubs)
    drugs to treat and prevent a variety of diseases.[citation needed] Different antithrombotics affect different blood clotting processes: Antiplatelet drugs...
    1 KB (129 words) - 15:50, 14 December 2021
  • Thumbnail for CYP2C19
    notably the antiplatelet treatment clopidogrel (Plavix), drugs that treat pain associated with ulcers, such as omeprazole, antiseizure drugs such as mephenytoin...
    39 KB (3,879 words) - 02:14, 11 August 2024